(旧版)高血圧治療ガイドライン2004

b 降圧薬を用いた心不全治療

20件/18件 1ページあたりの表示
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.//出典: N Engl J Med/ 349巻, 20号, 1893-906頁/ 発行年 2003年11月

著者: Pfeffer MA/McMurray JJ/Velazquez EJ/Rouleau JL/Kober L/Maggioni AP/Solomon SD/Swedberg K/Van de Werf F/White H/Leimberger JD/Henis M/Edwards S/Zelenkofske S/Sellers MA/Califf RM/Valsartan in Acute Myocardial Infarction Trial Investigators.

発行年: 2003

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.//出典: N Engl J Med/ 348巻, 14号, 1309-21頁/ 発行年 2003年04月

著者: Pitt B/Remme W/Zannad F/Neaton J/Martinez F/Roniker B/Bittman R/Hurley S/Kleiman J/Gatlin M/Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators.

発行年: 2003

Effects of treatment on morbidity in hypertension.//出典: JAMA/ 213巻, 1143-52頁/ 発行年 1970年

著者: VA Cooperative Study Group on Hypertensive Agents

発行年: 1970

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.//出典: Lancet/ 362巻, 9386号, 759-66頁/ 発行年 2003年09月

著者: Pfeffer MA/Swedberg K/Granger CB/Held P/McMurray JJ/Michelson EL/Olofsson B/Ostergren J/Yusuf S/Pocock S/CHARM Investigators and Committees.

発行年: 2003

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.//出典: Lancet/ 362巻, 9386号, 777-81頁/ 発行年 2003年09月

著者: Yusuf S/Pfeffer MA/Swedberg K/Granger CB/Held P/McMurray JJ/Michelson EL/Olofsson B/Ostergren J/CHARM Investigators and Committees.

発行年: 2003

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.//出典: JAMA/ 283巻, 10号, 1295-302頁/ 発行年 2000年03月

著者: Hjalmarson A/Goldstein S/Fagerberg B/Wedel H/Waagstein F/Kjekshus J/Wikstrand J/El Allaf D/Vitovec J/Aldershvile J/Halinen M/Dietz R/Neuhaus KL/Janosi A/Thorgeirsson G/Dunselman PH/Gullestad L/Kuch J/Herlitz J/Rickenbacher P/Ball S/Gottlieb S/Deedwania P

発行年: 2000

Effect of carvedilol on survival in severe chronic heart failure.//出典: N Engl J Med/ 344巻, 22号, 1651-8頁/ 発行年 2001年05月

著者: Packer M/Coats AJ/Fowler MB/Katus HA/Krum H/Mohacsi P/Rouleau JL/Tendera M/Castaigne A/Roecker EB/Schultz MK/DeMets DL/Carvedilol Prospective Randomized Cumulative Survival Study Group.

発行年: 2001

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guideli//出典: Circulation/ 104巻, 24号, 2996-3007頁/ 発行年 2001年12月

著者: Hunt SA/Baker DW/Chin MH/Cinquegrani MP/Feldman AM/Francis GS/Ganiats TG/Goldstein S/Gregoratos G/Jessup ML/Noble RJ/Packer M/Silver MA/Stevenson LW/Gibbons RJ/Antman EM/Alpert JS/Faxon DP/Fuster V/Gregoratos G/Jacobs AK/Hiratzka LF/Russell RO/Smith SC Jr

発行年: 2001

ページトップへ

ガイドライン解説

close-ico
カテゴリで探す
五十音で探す

診療ガイドライン検索

close-ico
カテゴリで探す
五十音で探す